Health Condition 1: O80- Encounter for full-term uncomplicated delivery
Conditions
Interventions
Intervention1: 25 mcg of misoprostol tablet: sublingually, and will be advised not to chew the tablet, or eat or drink for next 30minutes. Post medication NST will be done after 2 hours. Misoprostol
Sponsors
RamyaA
Eligibility
Inclusion criteria
Inclusion criteria: Single term pregnancies ( >37 weeks of gestational age) Live fetus â??Cephalic presentation. Reassuring fetal heart rate tracing. Pre-induction Bishopâ??s score of less than 6
Exclusion criteria
Exclusion criteria: Previous uterine scars. Estimated fetal weight on scan greater than 4 Amniotic fluid Index less than 5 cm. Fetal malformations. Any contraindication to vaginal delivery like placenta previa Contracted pelvis, Cephalopelvic disproportion Significant fetal or maternal comorbidities like severe pre- eclampsia or IUGR with doppler changes
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To compare the time taken for cervical ripening between sublingual misoprostol tablets and intracervical dinoprostone gel.Timepoint: To compare the time taken for cervical ripening between sublingual misoprostol tablets and intracervical dinoprostone gel. At baseline ,1 st group every 4 hours max 6 doses,2 nd group every 6 hours max 4 doses | — |
Secondary
| Measure | Time frame |
|---|---|
| To estimate the cumulative dose required in each group. To evaluate the feto-maternal outcome in both groups. Timepoint: Calculate total dose in 24 hours | — |
Countries
India
Contacts
Public ContactRamyaA
Pondicherry institute of medical sciences
Outcome results
None listed